HEALTHSOUTH (NYSE: HLS) is expected to report Q3 earnings on Oct. 25. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict HEALTHSOUTH's revenues will grow 4.8% and EPS will increase 41.7%.

The average estimate for revenue is $521.7 million. On the bottom line, the average EPS estimate is $0.34.

Revenue details
 Last quarter, HEALTHSOUTH notched revenue of $533.4 million. GAAP reported sales were 5.6% higher than the prior-year quarter's $505.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, non-GAAP EPS came in at $0.38. GAAP EPS of $0.43 for Q2 were 153% higher than the prior-year quarter's $0.17 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 46.9%, 10 basis points worse than the prior-year quarter. Operating margin was 19.4%, 170 basis points better than the prior-year quarter. Net margin was 8.8%, 450 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $2.13 billion. The average EPS estimate is $1.52.

Investor sentiment

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on HEALTHSOUTH is outperform, with an average price target of $25.46.